Latest Distributions News

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the six months ending December 2025, payable in April 2026 across multiple currencies.

EBOS Group Limited has updated its interim dividend details for the six months ending December 2025, confirming a fully franked ordinary dividend and a supplementary dividend, alongside a Dividend Reinvestment Plan offering a 2% discount.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending December 2025, payable in April 2026. The dividend is fully unfranked, reflecting foreign income components.

Premier Investments reported a modest 0.38% rise in net profit from continuing operations for the half-year ending January 2026, alongside a 3% increase in revenue and a fully franked interim dividend of 45 cents per share.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

Horizon Oil has released a first supplementary and replacement bidder’s statement for its off-market takeover offer for Cue Energy, proposing a mix of cash and shares that values Cue at a 10-14% premium. The deal aims to create a diversified oil and gas producer across Asia-Pacific with significant synergies.

Galileo Mining has reported encouraging drill assay results from its Norseman project, revealing consistent palladium-platinum-copper-nickel sulphide zones at the Mission Sill prospect and completing deep diamond drilling beneath the Callisto deposit.

OMG Group has appointed Food & Dairy Co as the first official distributor of its new matcha brands, opening access to over 2,000 cafes and restaurants in NSW and Queensland. This move marks a key step in OMG’s strategy to expand its health-focused beverage portfolio.

GR Engineering Services Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.12 per share and setting the Dividend Reinvestment Plan price at AUD 3.9507 with a 2.5% discount.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.

Tribeca Global Natural Resources has updated its dividend details for the six months ending December 2025, confirming a fully franked payout and finalising its Dividend Reinvestment Plan price.